Status:

COMPLETED

New Dermal Filler for Lip Augmentation

Lead Sponsor:

Galderma R&D

Conditions:

Lip Augmentation

Eligibility:

All Genders

22+ years

Phase:

NA

Brief Summary

To demonstrate non-inferiority of Kysse versus a control in lip fullness augmentation

Eligibility Criteria

Inclusion

  • Subjects willing to comply with the requirements of the study and providing a signed written informed consent.
  • Males or non-pregnant, non-breastfeeding females, 22 years of age or older.
  • Seeking augmentation therapy for the lips

Exclusion

  • Allergy of hypersensitivity to any injectable hyaluronic acid gel or to gram positive bacterial proteins.
  • Allergy or hypersensitivity to lidocaine or other amide-type anesthetics, or topical anesthetics or nerve blocking agents.

Key Trial Info

Start Date :

November 13 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 23 2019

Estimated Enrollment :

273 Patients enrolled

Trial Details

Trial ID

NCT03320824

Start Date

November 13 2017

End Date

April 23 2019

Last Update

August 26 2022

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

Clinical Testing of Bevelry Hills

Encino, California, United States, 91436

2

Cosmetic Laser Dermatology

San Diego, California, United States, 92121

3

Art of Skin MD

Solana Beach, California, United States, 92075

4

Skin Research Institute, LLC

Coral Gables, Florida, United States, 33146